SpineGuard SA (EPA:ALSGD)
France · Delayed Price · Currency is EUR 0.1070
-0.0016 (-1.50%)
Feb 5, 2026, 10:02 AM CET
SpineGuard Revenue
SpineGuard had revenue of 2.12M EUR in the half year ending June 30, 2025, a decrease of -5.10%. This brings the company's revenue in the last twelve months to 4.32M, down -4.47% year-over-year. In the year 2024, SpineGuard had annual revenue of 4.65M with 7.77% growth.
Revenue (ttm)
4.32M
Revenue Growth
-4.47%
P/S Ratio
2.21
Revenue / Employee
288.16K
Employees
15
Market Cap
9.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.65M | 335.24K | 7.77% |
| Dec 31, 2023 | 4.31M | -1.29M | -22.98% |
| Dec 31, 2022 | 5.60M | 1.19M | 27.11% |
| Dec 31, 2021 | 4.41M | -446.53K | -9.20% |
| Dec 31, 2020 | 4.85M | -1.98M | -28.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biosynex | 97.95M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Bluelinea Société Anonyme | 11.68M |
| Implanet | 11.10M |
| Mauna Kea Technologies | 8.18M |
| Carmat | 7.34M |